Class III

Drug Recall: Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61

Contract Pharmaceuticals Limited Canada · February 20, 2024

Reason for Recall

Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.

Distribution

Nationwide in the U.S. and Puerto Rico

States Affected

NATIONWIDE

Quantity Affected

45,875 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0364-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.